Tylvalosin Tartrate is a 16-membered semi-synthetic macrolide antibiotic that has activity against Gram-positive bacteria and Mycoplasmas. It is bacteriostatic and binds to the 23S rRNA of the 50S ribosomal unit, inhibiting bacterial protein synthesis.
Formulations containing Tylvalosin have been used in veterinary research to study Mycoplasma hyopneumoniae in swine, the causal agent of enzootic pneumonia. Since the compound can cause hypersensitivity reactions in laboratory animals, those with with known hypersensitivity to Tylvalosin should avoid contact with this product.
Tylvalosin Tartrate is soluble in water.